Caxton Associates (New York)’s Albemarle ALB Stock Holding History

Caxton Associates (New York)’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,881	Closed	-$1.86M	–	452
2023 Q4	$1.86M	Buy	12,881 +10,793	+517%	+$1.48M	0.1%	135
2023 Q3	$355K	Buy	+2,088	New	+$416K	0.05%	284
2023 Q2	–	Sell	-3,526	Closed	-$779K	–	481
2023 Q1	$779K	Buy	+3,526	New	+$869K	0.12%	193
2020 Q2	–	Sell	-5,069	Closed	-$286K	–	449
2020 Q1	$286K	Sell	5,069 -22,361	-82%	-$1.71M	0.05%	270
2019 Q4	$2M	Buy	+27,430	New	+$1.83M	0.27%	48
2019 Q3	–	Sell	-4,058	Closed	-$286K	–	385
2019 Q2	$286K	Sell	4,058 -6,209	-60%	-$458K	0.03%	295
2019 Q1	$842K	Buy	10,267 +3,671	+56%	+$300K	0.12%	88
2018 Q4	$508K	Buy	+6,596	New	+$622K	0.08%	118
2017 Q1	–	Sell	-110,000	Closed	-$9.47M	–	376
2016 Q4	$9.47M	Buy	+110,000	New	+$9.31M	0.43%	44
2013 Q3	–	Sell	-111,890	Closed	-$6.97M	–	167
2013 Q2	$6.97M	Buy	+111,890	New	+$7.03M	0.35%	64

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Caxton Associates (New York)'s ALB Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Albemarle (ALB) in Q1 2024, closing a stake of 12,881 shares — an estimated $1.86M sold.

Caxton Associates (New York) first reported a position in ALB in Q2 2013 and held it in 10 quarters. The position peaked at $9.47M in Q4 2016. 916 funds tracked by Wall St. Rank hold ALB as of Q1 2024.

Caxton Associates (New York) reported no remaining Albemarle position as of Q1 2024 after selling out during the quarter.
Caxton Associates (New York) sold 12,881 Albemarle shares in Q1 2024, an estimated $1.86M.
Caxton Associates (New York) first reported a position in Albemarle in Q2 2013 and held it in 10 quarters.
Caxton Associates (New York)'s Albemarle position peaked at $9.47M in Q4 2016.
916 funds tracked by Wall St. Rank held Albemarle as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.